ATXS
Price
$4.04
Change
+$0.06 (+1.51%)
Updated
Apr 17 closing price
Capitalization
227.99M
19 days until earnings call
TELO
Price
$2.48
Change
-$0.01 (-0.40%)
Updated
Apr 17 closing price
Capitalization
73.81M
39 days until earnings call
Ad is loading...

ATXS vs TELO

Header iconATXS vs TELO Comparison
Open Charts ATXS vs TELOBanner chart's image
Astria Therapeutics
Price$4.04
Change+$0.06 (+1.51%)
Volume$202.27K
Capitalization227.99M
Telomir Pharmaceuticals
Price$2.48
Change-$0.01 (-0.40%)
Volume$56.08K
Capitalization73.81M
ATXS vs TELO Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. TELO commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and TELO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (ATXS: $4.04 vs. TELO: $2.48)
Brand notoriety: ATXS and TELO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 68% vs. TELO: 32%
Market capitalization -- ATXS: $227.99M vs. TELO: $73.81M
ATXS [@Biotechnology] is valued at $227.99M. TELO’s [@Biotechnology] market capitalization is $73.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileTELO’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • TELO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than TELO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while TELO’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 4 bearish.
  • TELO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than TELO.

Price Growth

ATXS (@Biotechnology) experienced а -0.49% price change this week, while TELO (@Biotechnology) price change was -6.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

ATXS is expected to report earnings on Aug 11, 2025.

TELO is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($228M) has a higher market cap than TELO($73.8M). TELO YTD gains are higher at: -39.806 vs. ATXS (-54.810). TELO has higher annual earnings (EBITDA): -12.19M vs. ATXS (-111.56M). ATXS has more cash in the bank: 328M vs. TELO (1.27M). ATXS (0) and TELO (0) have equivalent revenues.
ATXSTELOATXS / TELO
Capitalization228M73.8M309%
EBITDA-111.56M-12.19M915%
Gain YTD-54.810-39.806138%
P/E RatioN/AN/A-
Revenue00-
Total Cash328M1.27M25,908%
Total Debt5.35MN/A-
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSTELO
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
82%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIGCX27.95N/A
N/A
Invesco Oppenheimer International Gr C
NSEPX18.87N/A
N/A
Columbia Select Large Cap Equity Inst
NVSCX26.10N/A
N/A
Allspring Small Company Growth Admin
KGDAX24.62N/A
N/A
DWS Global Small Cap A
PAHUX6.29N/A
N/A
PGIM Jennison NextGeneration Glb Opps Z

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with TRDA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+1.51%
TRDA - ATXS
52%
Loosely correlated
+3.44%
KYMR - ATXS
52%
Loosely correlated
+3.80%
XENE - ATXS
49%
Loosely correlated
+3.94%
APGE - ATXS
49%
Loosely correlated
+3.34%
DNLI - ATXS
49%
Loosely correlated
+1.51%
More

TELO and

Correlation & Price change

A.I.dvisor tells us that TELO and ENGN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELO and ENGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELO
1D Price
Change %
TELO100%
-0.40%
ENGN - TELO
29%
Poorly correlated
+1.01%
ATXS - TELO
27%
Poorly correlated
+1.51%
ALZN - TELO
27%
Poorly correlated
-5.63%
IRON - TELO
26%
Poorly correlated
+2.84%
ABOS - TELO
25%
Poorly correlated
-8.08%
More